Summaya Sohail Chaudry

Summaya Sohail Chaudry

Auto-generated profile, based on publicly available information

Summaya Sohail Chaudry

Pakistan Institute of Medical Science Islamabad Pakistan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMehreen Mushtaq
Mehreen Mushtaq
SCSummaya Sohail Chaudry
Summaya Sohail Chaudry
ASAhmareen Khalid Sheikh
Ahmareen Khalid Sheikh
NKNazia Khan
Nazia Khan
AKAsma Khattak
Asma Khattak
SRSyeda Kiran Riaz
Syeda Kiran Riaz
Background: Ki-67 is a proliferation marker that is used not only to categorize patients in luminal A and B subtypes of breast cancers, but also to determine the aggressiveness of the disease in triple negative and human epidermal growth factor 2 (HER2) over expressed molecular subtypes. The present study was designed to evaluate the role of Ki-67 with cut off value of 14% in molecular subgroups and its association with patient prognosis. Methods: Immunostaining was performed on histopathologically confirmed sections (n = 278) to assess expression of Ki-67, estrogen receptor (ER), progesterone receptor (PR) and HER2. Immunoreactivity of molecules was recorded as percentage scoring. Results: Adopting a cut off value of 14%, Ki-67 was high in 88%of the cases included in the study. High Ki-67 was significantly associated with pathological parameters including histological grade, advanced stage and nodal/distant metastasis. Immunoexpression of ER, PR and HER2 also showed strong correlation with high expression of Ki-67. Based on the St. Gallen classification, the cases were categorized into luminal A (10%) and luminal B (51%), triple negative (20%) and HER2 enriched (18%). Ki-67 index was also significantly high in 98% of HER2 enriched and 95% of TNBC patients. Interestingly, Ki-67 score with cut off value of 14% proved to be significant in deciphering prognosis in luminal patients. Moreover, high expression of Ki-67 also proved to be a marker of poor prognosis, especially in triple negative patients. Conclusion: We suggest that utilization of IHC4 status i.e. ER, PR, HER2 and Ki-67 along with pathological findings and molecular subtyping can considerably affect clinical as well as therapeutic decisions.

7 September 2026 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
ADAshiru Dahiru
Ashiru Dahiru
Ismat NawazIsmat Nawaz
Ismat Nawaz
SRSyeda Kiran Riaz
Syeda Kiran Riaz
NBNazneen Bangash
Nazneen Bangash
MTMuhammad Tayyab
Muhammad Tayyab
SESyed Ali Musstjab Akber Shah Eqani
Syed Ali Musstjab Akber Shah Eqani